Back

Adequacy of endogenous erythropoietin levels in anaemic heart failure patients - relationship with disease severity and co-morbidities

28 August 2016 (10:47 - 10:55)
Organised by:
Congress Presentation Part of: New targets for biomarkers in heart failure Pathophysiology and diagnosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Michal Tkaczyszyn

Wroclaw Medical University, Wroclaw (Poland)

6 More presentations in this session

Presentation thumbnail
NEOD001 demonstrates cardiac biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: results from the expansion phase of a phase 1/2 study
Assistant Professor M. Liedtke (Stanford, US)
Abstract
Presentation thumbnail
Changes in BNP prior to major cardiovascular events in patients with type 2 diabetes and a recent coronary event
Doctor E. Wolsk (Herlev, DK)
Abstract Slides
Presentation thumbnail
Novel biomarkers in heart failure with reduced and preserved ejection fraction in the general population
Doctor C. Sinning (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Increased levels of urinary biomarkers of tubular injury as a predictor of poor diuretic response in acute heart failure
Doctor M. Sokolski (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Association between brain natriuretic peptide levels and left ventricular ejection fraction in patients with preserved left ventricular ejection fraction.
Assistant Professor S. Kitada (Nagoya, JP)
Abstract Slides

Access the full session

Session thumbnail
New targets for biomarkers in heart failure

The Event

Event poster

ESC Congress 2016

28 August 2016 10:47 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources